Hospital Readmission as a Transcatheter Aortic Valve Replacement Performance Measure: Too Soon?

Editorial

. 2017 Jan;10(1):e004752.

doi: 10.1161/CIRCINTERVENTIONS.116.004752.

Affiliations

¹ From the Division of Cardiology, Duke University Medical Center and the Duke Clinical Research Institute, Durham, NC.
² From the Division of Cardiology, Duke University Medical Center and the Duke Clinical Research Institute, Durham, NC. sunil.rao@duke.edu.

Editorial

Rajesh V Swaminathan et al. Circ Cardiovasc Interv. 2017 Jan.

. 2017 Jan;10(1):e004752.

doi: 10.1161/CIRCINTERVENTIONS.116.004752.

¹ From the Division of Cardiology, Duke University Medical Center and the Duke Clinical Research Institute, Durham, NC.
² From the Division of Cardiology, Duke University Medical Center and the Duke Clinical Research Institute, Durham, NC. sunil.rao@duke.edu.

No abstract available

Keywords: Editorials; aortic valve stenosis; heart failure; medicare; outcome and process assessment.

Comment on

Thirty-Day Readmissions After Transcatheter Aortic Valve Replacement in the United States: Insights From the Nationwide Readmissions Database.
Kolte D, Khera S, Sardar MR, Gheewala N, Gupta T, Chatterjee S, Goldsweig A, Aronow WS, Fonarow GC, Bhatt DL, Greenbaum AB, Gordon PC, Sharaf B, Abbott JD. Kolte D, et al. Circ Cardiovasc Interv. 2017 Jan;10(1):e004472. doi: 10.1161/CIRCINTERVENTIONS.116.004472. Circ Cardiovasc Interv. 2017. PMID: 28034845